Share

March 28, 2017; 88 (13) Editorial

Variation in MS outcome

Race, place, or both?

Brian G. Weinshenker, Robyn M. Lucas
First published February 24, 2017, DOI: https://doi.org/10.1212/WNL.0000000000003776
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
116

Share

Article Information

vol. 88 no. 13 1214-1215
DOI: 
https://doi.org/10.1212/WNL.0000000000003776
PubMed: 
28235813
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published February 24, 2017.

Article Versions

Copyright & Usage: 
© 2017 American Academy of Neurology

Author Disclosures

    1. Brian G. Weinshenker, MD and
    2. Robyn M. Lucas, MBChB, PhD
  1. Brian G. Weinshenker, MD and
    2. Scientific Advisory Boards:

    1. (1) Novartis data safety monitoring board member (2) Biogen Idec data safety monitoring board member (3) Mitsubishi Pharmaceuticals data safety monitoring board member

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. 1. Canadian Journal of Neurological Sciences, editorial board member, 2006-present; no compensation 2. Turkish Journal of Neurology, editorial board member, 2005-present; no compensation 3. Neurology, editorial board member, 2014-present; no compensation

    Patents:

    1. 1) NMO-IgG for diagnosis of neuromyelitis optica; application 20050112116; patent issued and technology licensed to R.S.R. Ltd.,Oxford University,MVZ Labor PD Dr. Volkmann und Kollegen GbR, Hospices Civil de Lyon

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. (1)MedImmune Pharmaceuticals, Adjudication Committee Member (2)Alexion Pharmaceuticals, Adjudication Committee Member

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Guthy Jackson Charitable Foundation, sponsor of research in NMO, 10/2008-09/2011

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NMO-IgG for diagnosis of neuromyelitis optica; patent issued and technology licensed to R.S.R. Ltd., Oxford University, MVZ Labor PD Dr. Volkmann und Kollegen GbR and Hospices Civil de Lyon

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Robyn M. Lucas, MBChB, PhD
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Biogen-Idec: travel and accommodation costs (2007); (2) National Multiple Sclerosis Society of the USA: travel and accommodation costs (New York; 2009); (3) Euroskin: travel and accommodation costs (2005, 2007); (4) World Health Organization: travel and accommodation costs(2005); (5) ECTRIMS 2011: travel and accommodation costs; (6) 1st International conference on Skin Cancer prevention: travel and accommodation costs, 2011; (7) Australian Radiation Protection Society conference: travel and accommodation costs, 2011; (8) Vitamin D and MS prevention meeting, Dec 2011: travel and accommodation costs (9) Environment, Climate and Health conference (Copenhagen), April 2012: travel and accomodation costs 10) MS Frontiers conference UK, May 2013. Travel and accommodation costs 11) 2nd International conference on skin cancer prevention. Sept 2013 Travel and accommodation costs 12) 4th World Conference on Science and Technology Education. Oct 2013; travel and accommodation costs 13. Asia and Oceania conference on photobiology. Nov 2013. Travel, accommodation and registration paid 14. Vitamin D measurement challenges conference. Nov 2013. Travel and accommodation paid. 15. World Congress on cancers of the skin. contribution to travel and accommodation. 16. ILSI SEA Region Workshop on vitamin D in nutrition and health. Travel and accommodation paid. 17. European Society for Photobiology conference; contribution to travel and accommodation. 18. 3rd International conference on skin cancer prevention; travel and accommodation paid. 19. ECTRIMS focused workshop; travel and accommodation paid 20. UK MS Society meeting; travel and accommodation paid.

    Editorial Boards:

    1. I serve as an associate editor for the journal Photochemistry and Photobiology

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. (1) Euroskin 2007; (2) Contact Lens Association of Opthalmologists conference on Ultraviolet Radiation and its Effects on the Human Eye (3) Environment, Climate and Health conference

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) National Health and Medical Research Council of Australia,#585489, Chief investigator, 2010-2012; (2) National Health and Medical Research Council of Australia,#544922, Chief investigator, 2009-2011; (3) National Health and Medical Research Council of Australia,#497220, Chief investigator, 2008-2010; (4) National Health and Medical Research Council of Australia #1004898 Chief Investigator, 2012-2015; (5) National Health and Medical Research Council of Australia #1023987 Chief Investigator, 2012-2014 6. Cancer Australia #1045198 Chief Investigator, 2013-2015 7. National Health and Medical Research Council of Australia, #1067209 Chief Investigator, 2014-2016 8. Multiple Sclerosis Research Australia 14-041,Chief Investigator 2015 9. Multiple Sclerosis Research Australia 14-031, Chief Investigator 2015 10. National Research Foundation of South Africa, Chief Investigator, 2015 11. National Health and Medical Research Council of Australia #1121979 Chief Investigator, 2017-2020 12. National Health and Medical Research Council of Australia #1107343 Chief Investigator, 2016-2020 13. National Health and Medical Research Council of Australia #1127819 Chief Investigator, 2017-2021 National Health and Medical Research Council of Australia #1067209 Chief Investigator, 2012-2014

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology (B.G.W.), Mayo Clinic, Rochester, MN; and National Centre for Epidemiology and Population Health (R.M.L.), Research School of Population Health, College of Medicine, Biology and Environment, The Australian National University, Canberra, Australia.
  1. Correspondence to Dr. Weinshenker: weinb{at}mayo.edu
View Full Text

Article usage

Article usage: February 2017 to April 2022

AbstractFullPdfSource
Feb 2017363014Highwire
Mar 20178862740Highwire
Apr 20173701217Highwire
May 20172824Highwire
Jun 20174025Highwire
Jul 20172822Highwire
Aug 20172053Highwire
Sep 20171701Highwire
Oct 2017910Highwire
Nov 20171901Highwire
Dec 20171600Highwire
Jan 20182354Highwire
Feb 20182310Highwire
Mar 20182311Highwire
Apr 20182800Highwire
May 20183722Highwire
Jun 20184500Highwire
Jul 20182510Highwire
Aug 20182500Highwire
Sep 20181922Highwire
Oct 20182800Highwire
Nov 20182902Highwire
Dec 20182400Highwire
Jan 20191100Highwire
Feb 20194610Highwire
Mar 2019900Highwire
Apr 20192100Highwire
May 20192000Highwire
Jun 20191102Highwire
Jul 20191700Highwire
Aug 20191101Highwire
Sep 20192011Highwire
Oct 20191042Highwire
Nov 20191200Highwire
Dec 2019231Highwire
Jan 2020600Highwire
Feb 2020901Highwire
Mar 2020902Highwire
Apr 2020412Highwire
May 20201300Highwire
Jun 2020600Highwire
Jul 2020500Highwire
Aug 2020900Highwire
Sep 2020300Highwire
Oct 20201500Highwire
Nov 20201021Highwire
Dec 20201411Highwire
Jan 2021700Highwire
Feb 20212000Highwire
Mar 20211800Highwire
Apr 20211500Highwire
May 20211510Highwire
Jun 2021900Highwire
Jul 2021911Highwire
Aug 20211000Highwire
Sep 20215111Highwire
Oct 20212900Highwire
Nov 20212601Highwire
Dec 20212601Highwire
Jan 20221200Highwire
Feb 20221100Highwire
Mar 20221300Highwire
Apr 20221300Highwire

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me